$110M injection powers up Peninsula vaccine maker — but not for COVID-19

The vaccine, expected to produce data from a clinical trial in 2022, is designed to essentially carry 24 vaccines in one against pneumonia.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.